Lymphoma dissemination: the other face of lymphocyte homing
- PMID: 17656647
- DOI: 10.1182/blood-2007-05-075176
Lymphoma dissemination: the other face of lymphocyte homing
Abstract
The orchestration of systemic immune responses is critically dependent on coordinated lymphocyte migration and recirculation. This "homing" guides lymphocytes to the microenvironments that control their differentiation and survival, disperses the immunologic repertoire, and targets effector lymphocytes to sites of antigenic insult. Lymphocyte homing is a multistep process that requires chemotaxis and cell adhesion coupled with strategies to overcome physical barriers. At the molecular level, it is regulated by adhesion molecules and chemokines, and facilitated by intrinsic molecular programs that allow "ameboid" shape change, allowing highly effective lymphocyte traffic between different tissue compartments. In case of malignant transformation, however, the fact that lymphocytes are "licensed to move" forms a serious threat to the organism, because it permits rapid tumor dissemination irrespective of the conventional anatomic boundaries limiting early spread in most types of cancer. Thus, unlike the metastatic spread of other cancers, lymphoma dissemination generally is not a reflection of tumor progression but of conserved physiological behavior. The dissemination patterns often reflect basic rules of lymphocyte homing, explaining the strikingly tissue-specific dissemination of, for example, mucosal lymphomas, cutaneous lymphomas, and multiple myeloma. Understanding the molecular mechanisms underlying this behavior may provide novel targets for treatment of lymphoma patients.
Similar articles
-
Cell adhesion receptors in lymphoma dissemination.Blood. 2000 Mar 15;95(6):1900-10. Blood. 2000. PMID: 10706853 Review.
-
Adhesion molecules in the dissemination of non-Hodgkin's lymphomas.Acta Haematol. 1997;97(1-2):73-80. doi: 10.1159/000203662. Acta Haematol. 1997. PMID: 8980612 Review.
-
Preferential expression of the mucosal homing receptor integrin alpha 4 beta 7 in gastrointestinal non-Hodgkin's lymphomas.Am J Pathol. 1997 Mar;150(3):919-27. Am J Pathol. 1997. PMID: 9060830 Free PMC article.
-
Lymphocyte homing and homeostasis.Science. 1996 Apr 5;272(5258):60-6. doi: 10.1126/science.272.5258.60. Science. 1996. PMID: 8600538 Review.
-
Adhesion molecules in the prognosis of diffuse large-cell lymphoma: expression of a lymphocyte homing receptor (CD44), LFA-1 (CD11a/18), and ICAM-1 (CD54).Leukemia. 1990 Aug;4(8):595-9. Leukemia. 1990. PMID: 1974938
Cited by
-
The tumour microenvironment in B cell lymphomas.Nat Rev Cancer. 2014 Aug;14(8):517-34. doi: 10.1038/nrc3774. Epub 2014 Jul 10. Nat Rev Cancer. 2014. PMID: 25008267 Review.
-
Lymphoma dissemination is a pathological hallmark for malignant progression of B-cell lymphoma.Front Immunol. 2023 Nov 22;14:1286411. doi: 10.3389/fimmu.2023.1286411. eCollection 2023. Front Immunol. 2023. PMID: 38077394 Free PMC article.
-
Anti-CCR7 therapy exerts a potent anti-tumor activity in a xenograft model of human mantle cell lymphoma.J Hematol Oncol. 2013 Dec 4;6:89. doi: 10.1186/1756-8722-6-89. J Hematol Oncol. 2013. PMID: 24305507 Free PMC article.
-
Modeling Lymphoma Angiogenesis, Lymphangiogenesis, and Vessel Co-Option, and the Effects of Inhibition of Lymphoma-Vessel Interactions with an αCD20-EndoP125A Antibody Fusion Protein.Cells. 2024 Nov 6;13(22):1835. doi: 10.3390/cells13221835. Cells. 2024. PMID: 39594584 Free PMC article.
-
MYD88L265P and CD79B double mutations type (MCD type) of diffuse large B-cell lymphoma: mechanism, clinical characteristics, and targeted therapy.Ther Adv Hematol. 2022 Jan 31;13:20406207211072839. doi: 10.1177/20406207211072839. eCollection 2022. Ther Adv Hematol. 2022. PMID: 35126963 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical